Search

Andrew L Kung

from New York, NY
Age ~58
Get Report
Also known as:
Andrew Cindy Kung, Andrew C Kung, Jen Andrew Kung, Andrew L Lkung, Andy C Kung, Cindy Kung
Phone and address:
515 E 72Nd St APT 10K, New York, NY 10021
Related to:
Denise H Kung, 60
Connected to:
Cheung M Kung, 63Dean Kung, 62Dolly T Kung, 83Dominic Kung, 43Ernest C Kung, 94Frederick S Kung, 67Hsiang-Cheng Kung, 84Jaclyn K Kung, 41Jasmin Kung, 49Kristine J Kung, 37

Andrew Kung Phones & Addresses

  • 515 E 72Nd St APT 10K, New York, NY 10021
  • 129 Plimpton St, Walpole, MA 02081 (508) 668-8608
  • 113 Deforest St, Roslindale, MA 02131 (617) 325-1791
  • 54 Manthorne Rd, West Roxbury, MA 02132 (617) 325-1791
  • Jamaica Plain, MA
  • Menlo Park, CA
  • W Roxbury, MA
  • 129 Plimpton St, Walpole, MA 02081 (508) 633-2650

Work

Company: Visa Jun 2012 to Aug 2012 Address: London, United Kingdom Position: Summer analyst, london olympics

Education

Degree: B.S. School / High School: University of California, Berkeley 2009 to 2013 Specialities: Business Administration

Skills

Strategy • Leadership • Competitive Analysis • Public Speaking • Photography • Data Analysis • Market Research • Social Media • Sales • Marketing • E Commerce • Salesforce.com • Microsoft Office • Fundraising

Languages

English • Mandarin

Awards

1st place | deloitte consulting | human ... • 2nd place | credit union for berkeley st...

Interests

Children • Economic Empowerment • Civil Rights and Social Action • Education • Poverty Alleviation • Disaster and Humanitarian Relief

Industries

Photography

Professional Records

Medicine Doctors

Andrew Kung Photo 1

Dr. Andrew L Kung, Boston MA - MD (Doctor of Medicine)

View page
Specialties:
Pediatric Hematology & Oncology
Address:
Boston Office
450 Brookline Ave, Boston, MA 02215
(617) 632-3000 (Phone)

3959 Broadway, New York, NY 10032
(212) 342-3455 (Phone)

DANA-FARBER CANCER INSTITUTE
450 Brookline Ave, Boston, MA 02215
(617) 632-5117 (Phone)

DANA FARBER CANCER INSTITUTE
44 Binney St, Boston, MA 02115
(617) 632-3800 (Phone), (617) 632-3479 (Fax)
Certifications:
Pediatric Oncology & Pediatric Hematology, 2008
Pediatrics, 1999
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Boston Office
450 Brookline Ave, Boston, MA 02215

3959 Broadway, New York, NY 10032

DANA-FARBER CANCER INSTITUTE
450 Brookline Ave, Boston, MA 02215

DANA FARBER CANCER INSTITUTE
44 Binney St, Boston, MA 02115

Brigham and Women's Hospital
75 Francis Street, Boston, MA 02115

Massachusetts General Hospital
55 Fruit Street, Boston, MA 02114

North Shore Medical Center - Salem Hospital
81 Highland Avenue, Salem, MA 01970
Education:
Medical School
Stanford University School Of Medicine
Graduated: 1994
Medical School
Children's Hospital Boston
Graduated: 1996
Medical School
Dana Farber Canc Institute Chldns Hospital
Graduated: 1999
Andrew Kung Photo 2

Dr. Andrew Kung, New York NY - DDS (Doctor of Dental Surgery)

View page
Specialties:
Dentistry
Address:
345 E 24Th St, New York, NY 10010
(212) 998-9800 (Phone)
Languages:
English
Andrew Kung Photo 3

Andrew Kung, New York NY

View page
Specialties:
Dentist
Address:
345 E 24Th St, New York, NY 10010
Andrew Kung Photo 4

Andrew Li Jen Kung, Boston MA

View page
Specialties:
Pediatric Hematologist / Oncologist
Address:
44 Binney St, Boston, MA 02115
3959 Broadway, New York, NY 10032
450 Brookline Ave, Boston, MA 02215
Education:
Stanford University, School of Medicine - Doctor of Medicine
Stanford University, School of Medicine - Doctor of Philosophy
Board certifications:
American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)

Resumes

Resumes

Andrew Kung Photo 5

Photographer

View page
Location:
San Francisco, CA
Industry:
Photography
Work:
Visa - London, United Kingdom Jun 2012 - Aug 2012
Summer Analyst, London Olympics
Volunteer Action for Cambodia - Phnom Penh, Cambodia May 2012 - Jun 2012
Development Consultant & Non-Profit Volunteer
Johnson & Johnson Aug 2011 - May 2012
Innovation Strategy Intern
CDW - Berkeley, CA May 2011 - Jan 2012
Analyst Intern
Madera Group - Berkeley, CA May 2011 - Aug 2011
Business Analyst Intern
Education:
University of California, Berkeley 2009 - 2013
B.S., Business Administration University of California, Berkeley - Walter A. Haas School of Business 2009 - 2013
Sacred Heart Cathedral Preparatory 2005 - 2009
High School
Skills:
Strategy
Leadership
Competitive Analysis
Public Speaking
Photography
Data Analysis
Market Research
Social Media
Sales
Marketing
E Commerce
Salesforce.com
Microsoft Office
Fundraising
Interests:
Children
Economic Empowerment
Civil Rights and Social Action
Education
Poverty Alleviation
Disaster and Humanitarian Relief
Languages:
English
Mandarin
Awards:
1st Place | Deloitte Consulting | Human Capital Case Competition
2nd Place | Credit Union for Berkeley Students | Marketing Case Competition

Publications

Us Patents

Identification Of Compounds That Modify Transcriptional Responses To Hypoxia

View page
US Patent:
6986881, Jan 17, 2006
Filed:
Jun 2, 2000
Appl. No.:
10/009584
Inventors:
David M. Livingston - Brookline MA, US
Andrew L. Kung - Roslindale MA, US
Shoumo Bhattacharya - Oxford, GB
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A61K 49/00
C12N 15/63
C12N 5/10
C12N 15/85
US Classification:
424 91, 424 92, 424 96, 4353201, 435 6, 435 71, 435 29
Abstract:
The invention provides methods for identifying compounds that can be used to modify transcriptional responses to hypoxia, and use of such compounds in therapeutic and diagnostic methods.

Composition And Method For Imaging Cells

View page
US Patent:
7399851, Jul 15, 2008
Filed:
Jul 24, 2003
Appl. No.:
10/627075
Inventors:
David M. Livingston - Brookline MA, US
Andrew L. Kung - Walpole MA, US
Assignee:
Dana Farber Cancer Institute, Inc. - Boston MA
International Classification:
C07H 21/04
C07H 21/02
C12N 15/00
US Classification:
536 241, 536 231, 4353201
Abstract:
The invention relates to compositions containing a polynucleotide encoding for a reporter gene, a selectable marker and a regulatory element, that provide a method for imaging cells in vivo.

Composition And Method For Imaging Cells

View page
US Patent:
7732658, Jun 8, 2010
Filed:
Jul 10, 2008
Appl. No.:
12/218042
Inventors:
David M. Livingston - Brookline MA, US
Andrew L. Kung - Walpole MA, US
Assignee:
Dana Farber Cancer Institute, Inc. - Boston MA
International Classification:
A01K 67/027
C12N 15/00
G01N 33/00
US Classification:
800 18, 800 25, 800 3
Abstract:
The invention relates to compositions containing a polynucleotide encoding for a reporter gene, a selectable marker and a regulatory element, that provide a method for imaging cells in vivo.

Methods For Inhibiting Tumor Cell Growth

View page
US Patent:
7781393, Aug 24, 2010
Filed:
Feb 25, 2005
Appl. No.:
10/590672
Inventors:
Andrew Kung - Walpole MA, US
Constantine S. Mitsiades - Boston MA, US
Nicholos Mitsiades - W. Roxbury MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A01N 61/00
A61K 39/00
A61K 35/12
US Classification:
514 1, 4241841, 4242771
Abstract:
The invention methods using a insulin-like growth factor receptor inhibitor to inhibit tumor cell growth in a subject in need thereof.

Phosphospecific Chemokine Receptor Antibodies

View page
US Patent:
7892767, Feb 22, 2011
Filed:
Jun 30, 2006
Appl. No.:
11/994048
Inventors:
Joshua Rubin - Webster Groves MO, US
Andrew Kung - Walpole MA, US
Assignee:
Washington University in St. Louis - St. Louis MO
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
G01N 33/53
G01N 31/00
US Classification:
435 721, 435 71, 436 1, 436501, 436518, 424 91, 424520, 422 1, 422 50, 422 61, 530300, 530350
Abstract:
The present invention provides chemokine receptor antibodies that selectively bind to an activated form of the receptor but not to a non activated form of the receptor. In particular, the current invention provides phosphospecific chemokine receptor antibodies. The antibodies can be used in several diagnostic, screening and purification methods.

Identification Of Compounds That Modify Transcriptional Responses To Hypoxia

View page
US Patent:
20060172323, Aug 3, 2006
Filed:
Oct 28, 2005
Appl. No.:
11/261834
Inventors:
David Livingston - Brookline MA, US
Andrew Kung - Roslindale MA, US
Shoumo Bhattacharya - Oxford, GB
International Classification:
C12Q 1/68
G01N 33/53
A61K 38/17
US Classification:
435006000, 435007100, 514002000
Abstract:
The invention provides methods for identifying compounds that can be used to modify transcriptional responses to hypoxia, and use of such compounds in therapeutic and diagnostic methods.

Compositions For Detecting Cell Death And Methods Of Use Thereof

View page
US Patent:
20100034800, Feb 11, 2010
Filed:
Jul 29, 2009
Appl. No.:
12/511478
Inventors:
Andrew Kung - Walpole MA, US
Pallab Banerjee - Roslindale MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A61K 38/46
C12N 9/14
C07H 21/04
C12Q 1/34
US Classification:
424 946, 435195, 536 232, 435 18
Abstract:
The invention provides compounds and methods of their use in the detection of apoptosis and necrosis both in vitro and in vivo. Also provided are compounds and methods of their use in selective delivery of agents to cells undergoing apoptosis or necrosis. The compounds and methods are based on conjugates formed with a dehydrogenase such as lactate dehydrogenase, alcohol dehydrogenase, aldehyde dehydrogenase, and malate dehydrogenase. The compounds and methods are useful in the diagnosis and treatment of conditions characterized by apoptosis, including cancer, cardiac disease, neurologic disease including stroke, and autoimmunity. The compounds and methods offer distinct advantages over corresponding compounds and methods based on Annexin V. Also provided are methods for screening for compounds that modulate, i.e., inhibit or promote, apoptosis.

Nol3 Is A Predictor Of Patient Outcome

View page
US Patent:
20100179163, Jul 15, 2010
Filed:
Jan 11, 2010
Appl. No.:
12/685411
Inventors:
Andrew KUNG - Walpole MA, US
David ZIEGLER - Dover Heights, AU
International Classification:
A61K 31/496
C12Q 1/68
C07D 401/14
A61P 35/00
US Classification:
51425218, 435 6, 544295
Abstract:
The present invention features a method for determining the prognosis for survival of a cancer patient. Methods for measuring the level of NOL3 expression in a cancer cell-containing sample from a patient, and comparing the level of NOL3 expression in the sample to a reference level of NOL3 expression are also included. A higher level of NOL3 relative to the reference level correlates with decreased survival of the patient, and an equivalent or lower level of NOL3 relative to the reference level correlates with increased survival of the patient.
Control profile
Andrew L Kung from New York, NY, age ~58 Get Report